Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 2
1952 2
1953 4
1954 8
1955 4
1956 6
1957 1
1958 1
1960 1
1961 1
1962 1
1964 4
1965 7
1966 2
1967 2
1968 1
1969 2
1970 5
1971 2
1972 4
1974 3
1975 4
1979 1
1983 1
1984 1
1985 2
1987 2
1988 2
1989 3
1990 1
1993 1
1994 1
1996 4
1997 2
1998 2
1999 2
2000 7
2001 8
2002 7
2003 13
2004 12
2005 11
2006 8
2007 12
2008 15
2009 22
2010 26
2011 23
2012 20
2013 12
2014 11
2015 13
2016 15
2017 9
2018 9
2019 10
2020 6
2021 11
2022 11
2023 8
2024 12
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.
Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces YI, Pu AT, Singh AK, Videtic GM, McGarry RC, Iyengar P, Pantarotto JR, Urbanic JJ, Sun AY, Daly ME, Grills IS, Sperduto P, Normolle DP, Bradley JD, Choy H. Bezjak A, et al. J Clin Oncol. 2019 May 20;37(15):1316-1325. doi: 10.1200/JCO.18.00622. Epub 2019 Apr 3. J Clin Oncol. 2019. PMID: 30943123 Free PMC article. Clinical Trial.
Stereotactic Radiation Therapy in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Nonrandomized Clinical Trial.
Palma DA, Bahig H, Hope A, Harrow S, Debenham BJ, Louie AV, Vu TTTT, Filion E, Bezjak A, Campeau MP, Duimering A, Giuliani ME, Laba JM, Lang P, Lok BH, Qu XM, Raman S, Rodrigues GB, Goodman CD, Gaede S, Morisset J, Warner A, Dhaliwal I, Ryerson CJ. Palma DA, et al. JAMA Oncol. 2024 May 1;10(5):575-582. doi: 10.1001/jamaoncol.2023.7269. JAMA Oncol. 2024. PMID: 38451491 Free PMC article. Clinical Trial.
Rebuttal from Dr. Bezjak and Dr. Giuliani.
Giuliani M, Bezjak A. Giuliani M, et al. Transl Lung Cancer Res. 2016 Dec;5(6):658-659. doi: 10.21037/tlcr.2016.12.08. Transl Lung Cancer Res. 2016. PMID: 28151537 Free PMC article. No abstract available.
Hammer Wisely.
Safavi AH, Bezjak A. Safavi AH, et al. Int J Radiat Oncol Biol Phys. 2023 Jul 1;116(3):482-483. doi: 10.1016/j.ijrobp.2023.01.012. Int J Radiat Oncol Biol Phys. 2023. PMID: 37270245 No abstract available.
Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET).
Giuliani ME, Filion E, Faria S, Kundapur V, Toni Vu TTT, Lok BH, Raman S, Bahig H, Laba JM, Lang P, Louie AV, Hope A, Rodrigues GB, Bezjak A, Campeau MP, Duclos M, Bratman S, Swaminath A, Salunkhe R, Warner A, Palma DA. Giuliani ME, et al. Int J Radiat Oncol Biol Phys. 2024 Nov 1;120(3):669-677. doi: 10.1016/j.ijrobp.2024.03.050. Epub 2024 Apr 12. Int J Radiat Oncol Biol Phys. 2024. PMID: 38614279 Free article. Clinical Trial.
Stereotactic body radiation therapy for inoperable early stage lung cancer.
Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy H. Timmerman R, et al. JAMA. 2010 Mar 17;303(11):1070-6. doi: 10.1001/jama.2010.261. JAMA. 2010. PMID: 20233825 Free PMC article. Clinical Trial.
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.
Faivre-Finn C, Snee M, Ashcroft L, Appel W, Barlesi F, Bhatnagar A, Bezjak A, Cardenal F, Fournel P, Harden S, Le Pechoux C, McMenemin R, Mohammed N, O'Brien M, Pantarotto J, Surmont V, Van Meerbeeck JP, Woll PJ, Lorigan P, Blackhall F; CONVERT Study Team. Faivre-Finn C, et al. Lancet Oncol. 2017 Aug;18(8):1116-1125. doi: 10.1016/S1470-2045(17)30318-2. Epub 2017 Jun 20. Lancet Oncol. 2017. PMID: 28642008 Free PMC article. Clinical Trial.
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus.
Kong FM, Ritter T, Quint DJ, Senan S, Gaspar LE, Komaki RU, Hurkmans CW, Timmerman R, Bezjak A, Bradley JD, Movsas B, Marsh L, Okunieff P, Choy H, Curran WJ Jr. Kong FM, et al. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1442-57. doi: 10.1016/j.ijrobp.2010.07.1977. Epub 2010 Oct 8. Int J Radiat Oncol Biol Phys. 2011. PMID: 20934273 Free PMC article.
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
Schellenberg D, Gabos Z, Duimering A, Debenham B, Fairchild A, Huang F, Rowe LS, Severin D, Giuliani ME, Bezjak A, Lok BH, Raman S, Chung P, Zhao Y, Ho CK, Lock M, Louie AV, Lefresne S, Carolan H, Liu M, Yau V, Ye A, Olson RA, Mou B, Mohamed IG, Petrik DW, Dosani M, Pai H, Valev B, Gaede S, Warner A, Palma DA. Schellenberg D, et al. Int J Radiat Oncol Biol Phys. 2025 Jan 1;121(1):28-38. doi: 10.1016/j.ijrobp.2024.08.031. Epub 2024 Aug 19. Int J Radiat Oncol Biol Phys. 2025. PMID: 39168356 Clinical Trial.
The management of thymoma: a systematic review and practice guideline.
Falkson CB, Bezjak A, Darling G, Gregg R, Malthaner R, Maziak DE, Yu E, Smith CA, McNair S, Ung YC, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Falkson CB, et al. J Thorac Oncol. 2009 Jul;4(7):911-9. doi: 10.1097/jto.0b013e3181a4b8e0. J Thorac Oncol. 2009. PMID: 19557895 Free article.
372 results